• 22.6k views

Combatting TB: Prevention and Treatment Essentials

Combatting tuberculosis (TB) requires a multifaceted approach that includes both prevention and treatment strategies to effectively control the spread of the disease. Prevention efforts focus on identifying and treating latent TB infection, as well as implementing measures to reduce transmission in high-risk populations. Vaccination with the Bacillus Calmette-Guérin (BCG) vaccine in childhood is a key preventive measure, although its efficacy varies in different populations. Screening for TB infection through tuberculin skin tests or interferon-gamma release assays helps identify individuals at risk of developing active TB. Treatment of active TB involves a combination of antibiotics for an extended period, typically six to nine months, to ensure complete eradication of the bacteria. Directly Observed Therapy (DOT) programs help ensure medication adherence and reduce the risk of drug resistance. Drug-resistant TB strains pose a significant challenge, requiring specialized treatment regimens with second-line antibiotics and close monitoring.

About the Speaker

Dr. Padmanesan Narasimhan Profile Image

Dr. Padmanesan Narasimhan

Digital Health Roster of Experts at World Health Organization, Lecturer School of Public Health & Community Medicine, UNSW, Australia.

Dr. Padma Narasimhan is a Clinician and Lecturer at the School of Public Health. He started his career as a medical doctor in India for an Infectious disease clinic. He completed the Fogarty Ellison Clinical Research Fellowship at National Institutes of Health, USA in 2006 and moved to Australia . Dr. Padma Narasimhan was awarded the UNSW-University International Postgraduate Scholarship for a PhD at the School.

Upcoming Case Discussions

Leave a Comment

Your email address will not be published.

Author Post

authorimage

Impact

+

Talks

+

webinar

+

no.of registrations

One liner about speaker

Why is speaker relevant?

Dr. Padmanesan Narasimhan's Talks on Assimilate

webinar
Dr. Padmanesan Narasimhan
  • 22nd-March-2024, TIME : 4:00PM - 5:00PM
  • 0

Combatting tuberculosis (TB) requires a multifaceted approach that includes both prevention and treatment strategies to effectively control the spread of the disease. Prevention efforts focus on identifying and treating latent TB infection, as well as implementing measures to reduce transmission in high-risk populations. Vaccination with the Bacillus Calmette-Guérin (BCG) vaccine in childhood is a key preventive measure, although its efficacy varies in different populations. Screening for TB infection through tuberculin skin tests or interferon-gamma release assays helps identify individuals at risk of developing active TB. Treatment of active TB involves a combination of antibiotics for an extended period, typically six to nine months, to ensure complete eradication of the bacteria. Directly Observed Therapy (DOT) programs help ensure medication adherence and reduce the risk of drug resistance. Drug-resistant TB strains pose a significant challenge, requiring specialized treatment regimens with second-line antibiotics and close monitoring.

webinar
Dr. Padmanesan Narasimhan
  • 22nd-March-2024, TIME : 4:00PM - 5:00PM
  • 0

Combatting tuberculosis (TB) requires a multifaceted approach that includes both prevention and treatment strategies to effectively control the spread of the disease. Prevention efforts focus on identifying and treating latent TB infection, as well as implementing measures to reduce transmission in high-risk populations. Vaccination with the Bacillus Calmette-Guérin (BCG) vaccine in childhood is a key preventive measure, although its efficacy varies in different populations. Screening for TB infection through tuberculin skin tests or interferon-gamma release assays helps identify individuals at risk of developing active TB. Treatment of active TB involves a combination of antibiotics for an extended period, typically six to nine months, to ensure complete eradication of the bacteria. Directly Observed Therapy (DOT) programs help ensure medication adherence and reduce the risk of drug resistance. Drug-resistant TB strains pose a significant challenge, requiring specialized treatment regimens with second-line antibiotics and close monitoring.